Medical Science Director- CO, KS, TX, UT, NE

Lieu: United States - Field based

Fonction: Medical Affairs

Niveau de Séniorité: Director

Votre profil


Reporting to the Senior Medical Science Director Team Leader, the Medical Science Director (MSD) will participate in the strategic development and tactical execution of plans to engage scientific thought leaders and act as a conduit for providing accurate and updated clinical, scientific and medical information to Health Care Professionals and other members of the scientific community

  • Provide Non-Promotional Research Support

-       Develop clinical knowledge expertise in the hyperkalemia treatment landscape including current treatment strategies, and new therapeutic developments

-       Participate and sometimes lead the development and execution of medical strategies to identify key hyperkalemia/nephrology/heart failure experts, investigators, and institutions strategic to research and development efforts

-       Develop and ensure alignment in medical education activities for healthcare professionals through MSD-delivered presentations, participation in medical meetings, and other appropriate venues to enhance product and disease state knowledge

-       Collaborate with the company clinical team, medical monitors, CRAs, and CTEs to coordinate and optimize educational and research support for sites/investigators participating in the company’s clinical trials

-       Respond to unsolicited requests regarding interest in investigator sponsored studies (ISS), and support ISS submissions through appropriate internal review and approval processes 

-       Ensure alignment on content of effective clinical presentations provided to internal and external audiences, ensuring presentations are tailored to meet the specific needs of the audience (appropriate response to unsolicited requests)

-       Ensure efficient information exchange between MSD colleagues in the field and office-based clinical, medical affairs, and drug safety team members, so that key clinical, safety and research issues are identified and communicated to and from industry leaders and the appropriate departments to help shape company research, development, and strategies for investigational and commercialized Vifor portfolio products

-       Identify educational needs within the medical community around hyperkalemia disease state management

-       Maintain clinical expertise through comprehensive education including attendance at relevant symposiums and scientific workshops; review of key journals; and participation in required internal training and presentations


The knowledge and skills necessary to perform the duties of this position are typically acquired through the following combination of education, experience and knowledge, or the equivalent:

Minimum Requirements

-       MD, PharmD, PhD or other allied medical degree preferred and 2-5 years’ experience with a minimum of two years in field medical

-       Ability to travel 40-60%

-       Home-office based

Preferred Requirements

-       Knowledge and experience in the field of nephrology and/or cardiovascular medicine preferred

A propos de nous

Le groupe Vifor Pharma est une entreprise pharmaceutique internationale spécialisée. Son ambition est de devenir le leader mondial dans les domaines de la carence en fer, de la néphrologie et des traitements cardio-rénaux. L’entreprise est le partenaire de choix pour les médicaments et les solutions innovantes axées sur le patient. Le groupe Vifor Pharma aspire à aider les patients du monde entier atteints de maladies graves et chroniques à mener une vie meilleure et plus saine. La société développe, fabrique et commercialise des produits pharmaceutiques offrant des soins de précision aux patients. Le groupe Vifor Pharma occupe une position de premier plan dans toutes ses activités clés. Il se compose des entreprises suivantes: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma (sa société commune avec Fresenius Medical Care); et OM Pharma.

Le groupe Vifor Pharma a son siège en Suisse et est coté à la Bourse suisse (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

Pour de plus amples informations, veuillez consulter

Afficher/masquer le contenu

Xing Send to a friend

Conditions pour les agences de placement